nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—hematologic cancer	0.0588	1	CbGaD
Methadone—CYP2C18—Ifosfamide—hematologic cancer	0.0299	0.0472	CbGbCtD
Methadone—CYP1A2—Anagrelide—hematologic cancer	0.017	0.0269	CbGbCtD
Methadone—CYP2B6—Thiotepa—hematologic cancer	0.0167	0.0263	CbGbCtD
Methadone—CYP19A1—Betamethasone—hematologic cancer	0.0155	0.0245	CbGbCtD
Methadone—CYP2C9—Bexarotene—hematologic cancer	0.0106	0.0168	CbGbCtD
Methadone—ABCB1—Lenalidomide—hematologic cancer	0.0103	0.0163	CbGbCtD
Methadone—CYP3A7—Ifosfamide—hematologic cancer	0.00993	0.0157	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00993	0.0157	CbGbCtD
Methadone—CYP3A7—Imatinib—hematologic cancer	0.00949	0.015	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00949	0.015	CbGbCtD
Methadone—CYP2B6—Ifosfamide—hematologic cancer	0.00946	0.0149	CbGbCtD
Methadone—CYP2C8—Bortezomib—hematologic cancer	0.00934	0.0148	CbGbCtD
Methadone—CYP3A5—Daunorubicin—hematologic cancer	0.00929	0.0147	CbGbCtD
Methadone—CYP2D6—Lomustine—hematologic cancer	0.00903	0.0143	CbGbCtD
Methadone—CYP19A1—Dexamethasone—hematologic cancer	0.00901	0.0142	CbGbCtD
Methadone—CYP1A2—Carmustine—hematologic cancer	0.00894	0.0141	CbGbCtD
Methadone—CYP2C9—Idarubicin—hematologic cancer	0.00881	0.0139	CbGbCtD
Methadone—CYP3A5—Thalidomide—hematologic cancer	0.00846	0.0134	CbGbCtD
Methadone—CYP2B6—Nilotinib—hematologic cancer	0.00821	0.013	CbGbCtD
Methadone—CYP3A5—Teniposide—hematologic cancer	0.00807	0.0128	CbGbCtD
Methadone—CYP2D6—Idarubicin—hematologic cancer	0.00805	0.0127	CbGbCtD
Methadone—CYP19A1—ovarian follicle—hematologic cancer	0.0079	0.215	CbGeAlD
Methadone—CYP2C19—Bortezomib—hematologic cancer	0.00783	0.0124	CbGbCtD
Methadone—CYP1A2—Methoxsalen—hematologic cancer	0.0076	0.012	CbGbCtD
Methadone—CYP3A5—Ifosfamide—hematologic cancer	0.00745	0.0118	CbGbCtD
Methadone—CYP1A2—Bortezomib—hematologic cancer	0.00723	0.0114	CbGbCtD
Methadone—CYP2C8—Ifosfamide—hematologic cancer	0.00716	0.0113	CbGbCtD
Methadone—CYP3A5—Imatinib—hematologic cancer	0.00712	0.0112	CbGbCtD
Methadone—CYP1A2—Daunorubicin—hematologic cancer	0.00691	0.0109	CbGbCtD
Methadone—CYP2D6—Hydroxyurea—hematologic cancer	0.00685	0.0108	CbGbCtD
Methadone—CYP2C19—Thalidomide—hematologic cancer	0.00682	0.0108	CbGbCtD
Methadone—CYP1A2—Alitretinoin—hematologic cancer	0.00677	0.0107	CbGbCtD
Methadone—CYP2C9—Bortezomib—hematologic cancer	0.00651	0.0103	CbGbCtD
Methadone—CYP2C19—Teniposide—hematologic cancer	0.00651	0.0103	CbGbCtD
Methadone—CYP1A2—Thalidomide—hematologic cancer	0.0063	0.00995	CbGbCtD
Methadone—CYP2C8—Nilotinib—hematologic cancer	0.00622	0.00982	CbGbCtD
Methadone—CYP3A4—Bexarotene—hematologic cancer	0.00618	0.00976	CbGbCtD
Methadone—ABCB1—Daunorubicin—hematologic cancer	0.00605	0.00955	CbGbCtD
Methadone—CYP2C19—Ifosfamide—hematologic cancer	0.00601	0.00949	CbGbCtD
Methadone—CYP2D6—Bortezomib—hematologic cancer	0.00596	0.00941	CbGbCtD
Methadone—CYP3A7—Irinotecan—hematologic cancer	0.00592	0.00936	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00592	0.00936	CbGbCtD
Methadone—ABCB1—Alitretinoin—hematologic cancer	0.00592	0.00936	CbGbCtD
Methadone—CYP3A4—Busulfan—hematologic cancer	0.00574	0.00908	CbGbCtD
Methadone—CYP3A4—Lomustine—hematologic cancer	0.00574	0.00908	CbGbCtD
Methadone—CYP2C19—Imatinib—hematologic cancer	0.00574	0.00907	CbGbCtD
Methadone—CYP3A5—Dasatinib—hematologic cancer	0.00572	0.00903	CbGbCtD
Methadone—CYP2C9—Thalidomide—hematologic cancer	0.00567	0.00896	CbGbCtD
Methadone—CYP2B6—Irinotecan—hematologic cancer	0.00564	0.00891	CbGbCtD
Methadone—CYP1A2—Dacarbazine—hematologic cancer	0.00542	0.00856	CbGbCtD
Methadone—CYP2C9—Teniposide—hematologic cancer	0.00541	0.00855	CbGbCtD
Methadone—CYP1A2—Imatinib—hematologic cancer	0.0053	0.00837	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00518	0.00818	CbGbCtD
Methadone—CYP3A7—Vincristine—hematologic cancer	0.00518	0.00818	CbGbCtD
Methadone—CYP3A4—Thiotepa—hematologic cancer	0.00512	0.00809	CbGbCtD
Methadone—CYP2C9—Ifosfamide—hematologic cancer	0.005	0.00789	CbGbCtD
Methadone—CYP2C9—Imatinib—hematologic cancer	0.00477	0.00754	CbGbCtD
Methadone—ABCB1—Imatinib—hematologic cancer	0.00463	0.00732	CbGbCtD
Methadone—CYP2B6—Cisplatin—hematologic cancer	0.0046	0.00727	CbGbCtD
Methadone—CYP3A5—Irinotecan—hematologic cancer	0.00444	0.00702	CbGbCtD
Methadone—CYP2D6—Imatinib—hematologic cancer	0.00436	0.00689	CbGbCtD
Methadone—CYP2C9—Nilotinib—hematologic cancer	0.00434	0.00685	CbGbCtD
Methadone—CYP1A2—Dasatinib—hematologic cancer	0.00425	0.00672	CbGbCtD
Methadone—ABCB1—Nilotinib—hematologic cancer	0.00421	0.00665	CbGbCtD
Methadone—ABCB1—Vinorelbine—hematologic cancer	0.00417	0.00659	CbGbCtD
Methadone—CYP3A4—Methoxsalen—hematologic cancer	0.00398	0.00629	CbGbCtD
Methadone—CYP2D6—Nilotinib—hematologic cancer	0.00397	0.00626	CbGbCtD
Methadone—CYP2D6—Vinorelbine—hematologic cancer	0.00393	0.00621	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.0039	0.00616	CbGbCtD
Methadone—CYP3A7—Dexamethasone—hematologic cancer	0.0039	0.00616	CbGbCtD
Methadone—CYP3A5—Vincristine—hematologic cancer	0.00388	0.00614	CbGbCtD
Methadone—CYP3A4—Bortezomib—hematologic cancer	0.00379	0.00598	CbGbCtD
Methadone—CYP2C19—Prednisone—hematologic cancer	0.00378	0.00597	CbGbCtD
Methadone—ABCB1—Dasatinib—hematologic cancer	0.00372	0.00588	CbGbCtD
Methadone—CYP2B6—Dexamethasone—hematologic cancer	0.00372	0.00587	CbGbCtD
Methadone—ABCB1—Mitoxantrone—hematologic cancer	0.00367	0.0058	CbGbCtD
Methadone—CYP3A4—Daunorubicin—hematologic cancer	0.00362	0.00572	CbGbCtD
Methadone—CYP3A5—Etoposide—hematologic cancer	0.00356	0.00562	CbGbCtD
Methadone—CYP2C8—Etoposide—hematologic cancer	0.00342	0.00541	CbGbCtD
Methadone—ABCB1—Betamethasone—hematologic cancer	0.00327	0.00517	CbGbCtD
Methadone—ABCB1—Gemcitabine—hematologic cancer	0.00325	0.00513	CbGbCtD
Methadone—ABCB1—Prednisolone—hematologic cancer	0.00323	0.0051	CbGbCtD
Methadone—CYP3A4—Cytarabine—hematologic cancer	0.0032	0.00505	CbGbCtD
Methadone—CYP3A4—Teniposide—hematologic cancer	0.00315	0.00497	CbGbCtD
Methadone—CYP2B6—Doxorubicin—hematologic cancer	0.00308	0.00487	CbGbCtD
Methadone—ABCB1—Prednisone—hematologic cancer	0.00305	0.00482	CbGbCtD
Methadone—CYP3A5—Dexamethasone—hematologic cancer	0.00293	0.00462	CbGbCtD
Methadone—CYP3A4—Ifosfamide—hematologic cancer	0.0029	0.00459	CbGbCtD
Methadone—ABCB1—Irinotecan—hematologic cancer	0.00289	0.00457	CbGbCtD
Methadone—CYP2C8—Dexamethasone—hematologic cancer	0.00281	0.00445	CbGbCtD
Methadone—CYP3A4—Imatinib—hematologic cancer	0.00277	0.00438	CbGbCtD
Methadone—CHRNA10—hematopoietic system—hematologic cancer	0.00268	0.0728	CbGeAlD
Methadone—CYP1A2—Etoposide—hematologic cancer	0.00265	0.00419	CbGbCtD
Methadone—CYP3A4—Ruxolitinib—hematologic cancer	0.00261	0.00413	CbGbCtD
Methadone—ABCB1—Vinblastine—hematologic cancer	0.00257	0.00406	CbGbCtD
Methadone—ABCB1—Vincristine—hematologic cancer	0.00253	0.00399	CbGbCtD
Methadone—CYP3A4—Nilotinib—hematologic cancer	0.00252	0.00398	CbGbCtD
Methadone—CYP3A4—Vinorelbine—hematologic cancer	0.0025	0.00395	CbGbCtD
Methadone—CYP2C9—Cisplatin—hematologic cancer	0.00243	0.00384	CbGbCtD
Methadone—CYP2D6—Vinblastine—hematologic cancer	0.00242	0.00383	CbGbCtD
Methadone—CYP2C19—Dexamethasone—hematologic cancer	0.00236	0.00373	CbGbCtD
Methadone—ABCB1—Cisplatin—hematologic cancer	0.00236	0.00373	CbGbCtD
Methadone—ABCB1—Etoposide—hematologic cancer	0.00232	0.00366	CbGbCtD
Methadone—CYP3A4—Triamcinolone—hematologic cancer	0.00229	0.00361	CbGbCtD
Methadone—CYP3A4—Dasatinib—hematologic cancer	0.00223	0.00352	CbGbCtD
Methadone—CYP3A4—Mitoxantrone—hematologic cancer	0.0022	0.00348	CbGbCtD
Methadone—CYP2C9—Dexamethasone—hematologic cancer	0.00196	0.0031	CbGbCtD
Methadone—CYP3A4—Betamethasone—hematologic cancer	0.00196	0.0031	CbGbCtD
Methadone—CYP3A4—Prednisolone—hematologic cancer	0.00194	0.00306	CbGbCtD
Methadone—ABCB1—Dexamethasone—hematologic cancer	0.0019	0.00301	CbGbCtD
Methadone—CYP3A4—Prednisone—hematologic cancer	0.00183	0.00289	CbGbCtD
Methadone—CYP2D6—Dexamethasone—hematologic cancer	0.00179	0.00284	CbGbCtD
Methadone—CHRNA10—blood—hematologic cancer	0.00177	0.0482	CbGeAlD
Methadone—CYP3A4—Irinotecan—hematologic cancer	0.00173	0.00274	CbGbCtD
Methadone—ABCB1—Doxorubicin—hematologic cancer	0.00158	0.0025	CbGbCtD
Methadone—CYP3A4—Vinblastine—hematologic cancer	0.00154	0.00243	CbGbCtD
Methadone—ABCB1—Methotrexate—hematologic cancer	0.00153	0.00242	CbGbCtD
Methadone—CYP3A4—Vincristine—hematologic cancer	0.00151	0.00239	CbGbCtD
Methadone—CYP2D6—Doxorubicin—hematologic cancer	0.00149	0.00235	CbGbCtD
Methadone—CHRNA10—testis—hematologic cancer	0.00147	0.0399	CbGeAlD
Methadone—CYP3A4—Etoposide—hematologic cancer	0.00139	0.00219	CbGbCtD
Methadone—GRIN3A—testis—hematologic cancer	0.0013	0.0352	CbGeAlD
Methadone—HTR3A—hematopoietic system—hematologic cancer	0.00124	0.0337	CbGeAlD
Methadone—CYP3A4—Dexamethasone—hematologic cancer	0.00114	0.0018	CbGbCtD
Methadone—OPRM1—hematopoietic system—hematologic cancer	0.00114	0.0309	CbGeAlD
Methadone—CHRNA10—lymph node—hematologic cancer	0.00106	0.0289	CbGeAlD
Methadone—CYP19A1—hematopoietic system—hematologic cancer	0.000954	0.0259	CbGeAlD
Methadone—CYP3A4—Doxorubicin—hematologic cancer	0.000947	0.0015	CbGbCtD
Methadone—HTR3A—blood—hematologic cancer	0.000821	0.0223	CbGeAlD
Methadone—CYP2C19—hematopoietic system—hematologic cancer	0.000783	0.0213	CbGeAlD
Methadone—OPRM1—blood—hematologic cancer	0.000752	0.0205	CbGeAlD
Methadone—CYP19A1—gonad—hematologic cancer	0.000725	0.0197	CbGeAlD
Methadone—HTR3A—lung—hematologic cancer	0.000719	0.0196	CbGeAlD
Methadone—CYP2C8—hematopoietic system—hematologic cancer	0.000683	0.0186	CbGeAlD
Methadone—CYP1A2—hematopoietic system—hematologic cancer	0.000639	0.0174	CbGeAlD
Methadone—CYP19A1—blood—hematologic cancer	0.000632	0.0172	CbGeAlD
Methadone—OPRM1—testis—hematologic cancer	0.000622	0.0169	CbGeAlD
Methadone—CYP3A5—hematopoietic system—hematologic cancer	0.000617	0.0168	CbGeAlD
Methadone—CYP2B6—hematopoietic system—hematologic cancer	0.000613	0.0167	CbGeAlD
Methadone—CYP2C9—hematopoietic system—hematologic cancer	0.000607	0.0165	CbGeAlD
Methadone—CYP19A1—testis—hematologic cancer	0.000523	0.0142	CbGeAlD
Methadone—CYP2C19—blood—hematologic cancer	0.000519	0.0141	CbGeAlD
Methadone—CYP2B6—gonad—hematologic cancer	0.000466	0.0127	CbGeAlD
Methadone—CYP3A4—hematopoietic system—hematologic cancer	0.000463	0.0126	CbGeAlD
Methadone—CYP2D6—hematopoietic system—hematologic cancer	0.000455	0.0124	CbGeAlD
Methadone—CYP2C8—blood—hematologic cancer	0.000453	0.0123	CbGeAlD
Methadone—CYP1A2—blood—hematologic cancer	0.000424	0.0115	CbGeAlD
Methadone—CYP3A5—blood—hematologic cancer	0.000408	0.0111	CbGeAlD
Methadone—CYP2B6—blood—hematologic cancer	0.000406	0.011	CbGeAlD
Methadone—CYP2C9—blood—hematologic cancer	0.000402	0.0109	CbGeAlD
Methadone—CYP19A1—lymph node—hematologic cancer	0.000379	0.0103	CbGeAlD
Methadone—CYP2C8—testis—hematologic cancer	0.000374	0.0102	CbGeAlD
Methadone—CYP1A2—lung—hematologic cancer	0.000371	0.0101	CbGeAlD
Methadone—CYP3A5—lung—hematologic cancer	0.000358	0.00974	CbGeAlD
Methadone—CYP2B6—lung—hematologic cancer	0.000356	0.00968	CbGeAlD
Methadone—CYP2B6—testis—hematologic cancer	0.000336	0.00913	CbGeAlD
Methadone—ABCB1—hematopoietic system—hematologic cancer	0.000328	0.00891	CbGeAlD
Methadone—CYP3A4—blood—hematologic cancer	0.000307	0.00834	CbGeAlD
Methadone—CYP2D6—blood—hematologic cancer	0.000302	0.0082	CbGeAlD
Methadone—CYP2D6—testis—hematologic cancer	0.00025	0.00679	CbGeAlD
Methadone—ABCB1—gonad—hematologic cancer	0.000249	0.00677	CbGeAlD
Methadone—Clotrimazole—ABCC3—hematologic cancer	0.000232	0.221	CrCbGaD
Methadone—ABCB1—blood—hematologic cancer	0.000217	0.0059	CbGeAlD
Methadone—ABCB1—bone marrow—hematologic cancer	0.00021	0.00571	CbGeAlD
Methadone—Disopyramide—SLC22A1—hematologic cancer	0.000197	0.189	CrCbGaD
Methadone—ABCB1—lung—hematologic cancer	0.00019	0.00517	CbGeAlD
Methadone—ABCB1—testis—hematologic cancer	0.000179	0.00488	CbGeAlD
Methadone—ABCB1—lymph node—hematologic cancer	0.00013	0.00354	CbGeAlD
Methadone—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000117	0.112	CrCbGaD
Methadone—Diphenhydramine—SLC22A1—hematologic cancer	9.78e-05	0.0935	CrCbGaD
Methadone—Tamoxifen—ABCG2—hematologic cancer	6.65e-05	0.0636	CrCbGaD
Methadone—Tamoxifen—ESR1—hematologic cancer	6.51e-05	0.0623	CrCbGaD
Methadone—Fexofenadine—ABCB1—hematologic cancer	6.06e-05	0.058	CrCbGaD
Methadone—Clotrimazole—ABCB1—hematologic cancer	4.68e-05	0.0448	CrCbGaD
Methadone—Fentanyl—ABCB1—hematologic cancer	4e-05	0.0383	CrCbGaD
Methadone—Dermatitis—Ifosfamide—hematologic cancer	3.96e-05	0.000193	CcSEcCtD
Methadone—Hyperhidrosis—Betamethasone—hematologic cancer	3.95e-05	0.000192	CcSEcCtD
Methadone—Hyperhidrosis—Dexamethasone—hematologic cancer	3.95e-05	0.000192	CcSEcCtD
Methadone—Dizziness—Irinotecan—hematologic cancer	3.95e-05	0.000192	CcSEcCtD
Methadone—Urticaria—Etoposide—hematologic cancer	3.94e-05	0.000192	CcSEcCtD
Methadone—Body temperature increased—Etoposide—hematologic cancer	3.93e-05	0.000191	CcSEcCtD
Methadone—Abdominal pain—Etoposide—hematologic cancer	3.93e-05	0.000191	CcSEcCtD
Methadone—Vertigo—Prednisone—hematologic cancer	3.92e-05	0.000191	CcSEcCtD
Methadone—Syncope—Prednisone—hematologic cancer	3.91e-05	0.00019	CcSEcCtD
Methadone—Vomiting—Vincristine—hematologic cancer	3.9e-05	0.00019	CcSEcCtD
Methadone—Anorexia—Betamethasone—hematologic cancer	3.9e-05	0.00019	CcSEcCtD
Methadone—Anorexia—Dexamethasone—hematologic cancer	3.9e-05	0.00019	CcSEcCtD
Methadone—Urticaria—Prednisolone—hematologic cancer	3.89e-05	0.000189	CcSEcCtD
Methadone—Asthenia—Cisplatin—hematologic cancer	3.89e-05	0.000189	CcSEcCtD
Methadone—Sweating—Doxorubicin—hematologic cancer	3.87e-05	0.000188	CcSEcCtD
Methadone—Rash—Vincristine—hematologic cancer	3.87e-05	0.000188	CcSEcCtD
Methadone—Dermatitis—Vincristine—hematologic cancer	3.86e-05	0.000188	CcSEcCtD
Methadone—Loperamide—ABCB1—hematologic cancer	3.85e-05	0.0369	CrCbGaD
Methadone—Pain—Triamcinolone—hematologic cancer	3.85e-05	0.000187	CcSEcCtD
Methadone—Headache—Vincristine—hematologic cancer	3.84e-05	0.000187	CcSEcCtD
Methadone—Loss of consciousness—Prednisone—hematologic cancer	3.83e-05	0.000187	CcSEcCtD
Methadone—Hypotension—Dexamethasone—hematologic cancer	3.82e-05	0.000186	CcSEcCtD
Methadone—Hypotension—Betamethasone—hematologic cancer	3.82e-05	0.000186	CcSEcCtD
Methadone—Nausea—Carmustine—hematologic cancer	3.81e-05	0.000186	CcSEcCtD
Methadone—Vomiting—Mitoxantrone—hematologic cancer	3.8e-05	0.000185	CcSEcCtD
Methadone—Vomiting—Irinotecan—hematologic cancer	3.8e-05	0.000185	CcSEcCtD
Methadone—Nausea—Alitretinoin—hematologic cancer	3.78e-05	0.000184	CcSEcCtD
Methadone—Convulsion—Prednisone—hematologic cancer	3.78e-05	0.000184	CcSEcCtD
Methadone—Visual impairment—Epirubicin—hematologic cancer	3.78e-05	0.000184	CcSEcCtD
Methadone—Rash—Irinotecan—hematologic cancer	3.76e-05	0.000183	CcSEcCtD
Methadone—Rash—Mitoxantrone—hematologic cancer	3.76e-05	0.000183	CcSEcCtD
Methadone—Dermatitis—Mitoxantrone—hematologic cancer	3.76e-05	0.000183	CcSEcCtD
Methadone—Dermatitis—Irinotecan—hematologic cancer	3.76e-05	0.000183	CcSEcCtD
Methadone—Chills—Methotrexate—hematologic cancer	3.76e-05	0.000183	CcSEcCtD
Methadone—Headache—Irinotecan—hematologic cancer	3.74e-05	0.000182	CcSEcCtD
Methadone—Headache—Mitoxantrone—hematologic cancer	3.74e-05	0.000182	CcSEcCtD
Methadone—Nausea—Ifosfamide—hematologic cancer	3.73e-05	0.000182	CcSEcCtD
Methadone—Feeling abnormal—Triamcinolone—hematologic cancer	3.71e-05	0.000181	CcSEcCtD
Methadone—Diarrhoea—Cisplatin—hematologic cancer	3.71e-05	0.00018	CcSEcCtD
Methadone—Anxiety—Prednisone—hematologic cancer	3.7e-05	0.00018	CcSEcCtD
Methadone—Vomiting—Gemcitabine—hematologic cancer	3.7e-05	0.00018	CcSEcCtD
Methadone—Insomnia—Dexamethasone—hematologic cancer	3.7e-05	0.00018	CcSEcCtD
Methadone—Insomnia—Betamethasone—hematologic cancer	3.7e-05	0.00018	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—hematologic cancer	3.69e-05	0.00018	CcSEcCtD
Methadone—Rash—Gemcitabine—hematologic cancer	3.67e-05	0.000178	CcSEcCtD
Methadone—Dermatitis—Gemcitabine—hematologic cancer	3.66e-05	0.000178	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—hematologic cancer	3.66e-05	0.000178	CcSEcCtD
Methadone—Erythema—Methotrexate—hematologic cancer	3.64e-05	0.000177	CcSEcCtD
Methadone—Headache—Gemcitabine—hematologic cancer	3.64e-05	0.000177	CcSEcCtD
Methadone—Nausea—Vincristine—hematologic cancer	3.64e-05	0.000177	CcSEcCtD
Methadone—Flushing—Epirubicin—hematologic cancer	3.64e-05	0.000177	CcSEcCtD
Methadone—Hypersensitivity—Prednisolone—hematologic cancer	3.61e-05	0.000176	CcSEcCtD
Methadone—Urticaria—Triamcinolone—hematologic cancer	3.58e-05	0.000174	CcSEcCtD
Methadone—Asthenia—Etoposide—hematologic cancer	3.56e-05	0.000173	CcSEcCtD
Methadone—Body temperature increased—Triamcinolone—hematologic cancer	3.56e-05	0.000173	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—hematologic cancer	3.56e-05	0.000173	CcSEcCtD
Methadone—Oedema—Prednisone—hematologic cancer	3.56e-05	0.000173	CcSEcCtD
Methadone—Decreased appetite—Betamethasone—hematologic cancer	3.55e-05	0.000173	CcSEcCtD
Methadone—Decreased appetite—Dexamethasone—hematologic cancer	3.55e-05	0.000173	CcSEcCtD
Methadone—Nausea—Irinotecan—hematologic cancer	3.55e-05	0.000173	CcSEcCtD
Methadone—Nausea—Mitoxantrone—hematologic cancer	3.55e-05	0.000173	CcSEcCtD
Methadone—Chills—Epirubicin—hematologic cancer	3.52e-05	0.000171	CcSEcCtD
Methadone—Pruritus—Etoposide—hematologic cancer	3.51e-05	0.000171	CcSEcCtD
Methadone—Shock—Prednisone—hematologic cancer	3.5e-05	0.00017	CcSEcCtD
Methadone—Arrhythmia—Epirubicin—hematologic cancer	3.5e-05	0.00017	CcSEcCtD
Methadone—Pain—Betamethasone—hematologic cancer	3.49e-05	0.00017	CcSEcCtD
Methadone—Pain—Dexamethasone—hematologic cancer	3.49e-05	0.00017	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—hematologic cancer	3.49e-05	0.00017	CcSEcCtD
Methadone—Tachycardia—Prednisone—hematologic cancer	3.47e-05	0.000169	CcSEcCtD
Methadone—Nausea—Gemcitabine—hematologic cancer	3.45e-05	0.000168	CcSEcCtD
Methadone—Vomiting—Cisplatin—hematologic cancer	3.45e-05	0.000168	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—hematologic cancer	3.44e-05	0.000167	CcSEcCtD
Methadone—Rash—Cisplatin—hematologic cancer	3.42e-05	0.000166	CcSEcCtD
Methadone—Dermatitis—Cisplatin—hematologic cancer	3.41e-05	0.000166	CcSEcCtD
Methadone—Erythema—Epirubicin—hematologic cancer	3.41e-05	0.000166	CcSEcCtD
Methadone—Diarrhoea—Etoposide—hematologic cancer	3.4e-05	0.000165	CcSEcCtD
Methadone—Anorexia—Prednisone—hematologic cancer	3.39e-05	0.000165	CcSEcCtD
Methadone—Feeling abnormal—Betamethasone—hematologic cancer	3.37e-05	0.000164	CcSEcCtD
Methadone—Feeling abnormal—Dexamethasone—hematologic cancer	3.37e-05	0.000164	CcSEcCtD
Methadone—Flushing—Doxorubicin—hematologic cancer	3.36e-05	0.000164	CcSEcCtD
Methadone—Gastrointestinal pain—Betamethasone—hematologic cancer	3.34e-05	0.000163	CcSEcCtD
Methadone—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.34e-05	0.000163	CcSEcCtD
Methadone—Hypersensitivity—Triamcinolone—hematologic cancer	3.32e-05	0.000161	CcSEcCtD
Methadone—Dizziness—Etoposide—hematologic cancer	3.28e-05	0.00016	CcSEcCtD
Methadone—Muscle spasms—Epirubicin—hematologic cancer	3.28e-05	0.00016	CcSEcCtD
Methadone—Vertigo—Methotrexate—hematologic cancer	3.27e-05	0.000159	CcSEcCtD
Methadone—Chills—Doxorubicin—hematologic cancer	3.25e-05	0.000158	CcSEcCtD
Methadone—Urticaria—Dexamethasone—hematologic cancer	3.25e-05	0.000158	CcSEcCtD
Methadone—Urticaria—Betamethasone—hematologic cancer	3.25e-05	0.000158	CcSEcCtD
Methadone—Dizziness—Prednisolone—hematologic cancer	3.24e-05	0.000158	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—hematologic cancer	3.24e-05	0.000158	CcSEcCtD
Methadone—Asthenia—Triamcinolone—hematologic cancer	3.23e-05	0.000157	CcSEcCtD
Methadone—Abdominal pain—Betamethasone—hematologic cancer	3.23e-05	0.000157	CcSEcCtD
Methadone—Body temperature increased—Betamethasone—hematologic cancer	3.23e-05	0.000157	CcSEcCtD
Methadone—Abdominal pain—Dexamethasone—hematologic cancer	3.23e-05	0.000157	CcSEcCtD
Methadone—Body temperature increased—Dexamethasone—hematologic cancer	3.23e-05	0.000157	CcSEcCtD
Methadone—Nausea—Cisplatin—hematologic cancer	3.22e-05	0.000157	CcSEcCtD
Methadone—Insomnia—Prednisone—hematologic cancer	3.22e-05	0.000157	CcSEcCtD
Methadone—Pruritus—Triamcinolone—hematologic cancer	3.19e-05	0.000155	CcSEcCtD
Methadone—Convulsion—Methotrexate—hematologic cancer	3.16e-05	0.000154	CcSEcCtD
Methadone—Vomiting—Etoposide—hematologic cancer	3.16e-05	0.000154	CcSEcCtD
Methadone—Erythema—Doxorubicin—hematologic cancer	3.16e-05	0.000154	CcSEcCtD
Methadone—Agitation—Epirubicin—hematologic cancer	3.13e-05	0.000153	CcSEcCtD
Methadone—Rash—Etoposide—hematologic cancer	3.13e-05	0.000152	CcSEcCtD
Methadone—Dermatitis—Etoposide—hematologic cancer	3.13e-05	0.000152	CcSEcCtD
Methadone—Headache—Etoposide—hematologic cancer	3.11e-05	0.000151	CcSEcCtD
Methadone—Decreased appetite—Prednisone—hematologic cancer	3.09e-05	0.000151	CcSEcCtD
Methadone—Rash—Prednisolone—hematologic cancer	3.09e-05	0.00015	CcSEcCtD
Methadone—Dermatitis—Prednisolone—hematologic cancer	3.09e-05	0.00015	CcSEcCtD
Methadone—Headache—Prednisolone—hematologic cancer	3.07e-05	0.000149	CcSEcCtD
Methadone—Vertigo—Epirubicin—hematologic cancer	3.06e-05	0.000149	CcSEcCtD
Methadone—Syncope—Epirubicin—hematologic cancer	3.06e-05	0.000149	CcSEcCtD
Methadone—Constipation—Prednisone—hematologic cancer	3.04e-05	0.000148	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—hematologic cancer	3.03e-05	0.000148	CcSEcCtD
Methadone—Palpitations—Epirubicin—hematologic cancer	3.01e-05	0.000147	CcSEcCtD
Methadone—Confusional state—Methotrexate—hematologic cancer	3e-05	0.000146	CcSEcCtD
Methadone—Loss of consciousness—Epirubicin—hematologic cancer	3e-05	0.000146	CcSEcCtD
Methadone—Dizziness—Triamcinolone—hematologic cancer	2.98e-05	0.000145	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—hematologic cancer	2.97e-05	0.000145	CcSEcCtD
Methadone—Convulsion—Epirubicin—hematologic cancer	2.96e-05	0.000144	CcSEcCtD
Methadone—Nausea—Etoposide—hematologic cancer	2.95e-05	0.000144	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—hematologic cancer	2.93e-05	0.000143	CcSEcCtD
Methadone—Asthenia—Betamethasone—hematologic cancer	2.93e-05	0.000143	CcSEcCtD
Methadone—Asthenia—Dexamethasone—hematologic cancer	2.93e-05	0.000143	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—hematologic cancer	2.91e-05	0.000142	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—hematologic cancer	2.91e-05	0.000142	CcSEcCtD
Methadone—Nausea—Prednisolone—hematologic cancer	2.91e-05	0.000142	CcSEcCtD
Methadone—Agitation—Doxorubicin—hematologic cancer	2.9e-05	0.000141	CcSEcCtD
Methadone—Trimipramine—ABCB1—hematologic cancer	2.89e-05	0.0277	CrCbGaD
Methadone—Anxiety—Epirubicin—hematologic cancer	2.89e-05	0.000141	CcSEcCtD
Methadone—Pruritus—Dexamethasone—hematologic cancer	2.89e-05	0.000141	CcSEcCtD
Methadone—Pruritus—Betamethasone—hematologic cancer	2.89e-05	0.000141	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—hematologic cancer	2.88e-05	0.00014	CcSEcCtD
Methadone—Vomiting—Triamcinolone—hematologic cancer	2.86e-05	0.000139	CcSEcCtD
Methadone—Rash—Triamcinolone—hematologic cancer	2.84e-05	0.000138	CcSEcCtD
Methadone—Dry mouth—Epirubicin—hematologic cancer	2.84e-05	0.000138	CcSEcCtD
Methadone—Dermatitis—Triamcinolone—hematologic cancer	2.84e-05	0.000138	CcSEcCtD
Methadone—Vertigo—Doxorubicin—hematologic cancer	2.84e-05	0.000138	CcSEcCtD
Methadone—Anorexia—Methotrexate—hematologic cancer	2.84e-05	0.000138	CcSEcCtD
Methadone—Syncope—Doxorubicin—hematologic cancer	2.83e-05	0.000138	CcSEcCtD
Methadone—Urticaria—Prednisone—hematologic cancer	2.83e-05	0.000138	CcSEcCtD
Methadone—Headache—Triamcinolone—hematologic cancer	2.82e-05	0.000137	CcSEcCtD
Methadone—Abdominal pain—Prednisone—hematologic cancer	2.81e-05	0.000137	CcSEcCtD
Methadone—Body temperature increased—Prednisone—hematologic cancer	2.81e-05	0.000137	CcSEcCtD
Methadone—Confusional state—Epirubicin—hematologic cancer	2.81e-05	0.000137	CcSEcCtD
Methadone—Diarrhoea—Dexamethasone—hematologic cancer	2.8e-05	0.000136	CcSEcCtD
Methadone—Diarrhoea—Betamethasone—hematologic cancer	2.8e-05	0.000136	CcSEcCtD
Methadone—Palpitations—Doxorubicin—hematologic cancer	2.79e-05	0.000136	CcSEcCtD
Methadone—Promethazine—ABCB1—hematologic cancer	2.79e-05	0.0267	CrCbGaD
Methadone—Anaphylactic shock—Epirubicin—hematologic cancer	2.78e-05	0.000135	CcSEcCtD
Methadone—Oedema—Epirubicin—hematologic cancer	2.78e-05	0.000135	CcSEcCtD
Methadone—Hypotension—Methotrexate—hematologic cancer	2.78e-05	0.000135	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—hematologic cancer	2.77e-05	0.000135	CcSEcCtD
Methadone—Tamoxifen—ABCB1—hematologic cancer	2.77e-05	0.0265	CrCbGaD
Methadone—Shock—Epirubicin—hematologic cancer	2.74e-05	0.000133	CcSEcCtD
Methadone—Convulsion—Doxorubicin—hematologic cancer	2.73e-05	0.000133	CcSEcCtD
Methadone—Thrombocytopenia—Epirubicin—hematologic cancer	2.73e-05	0.000133	CcSEcCtD
Methadone—Tachycardia—Epirubicin—hematologic cancer	2.72e-05	0.000132	CcSEcCtD
Methadone—Dizziness—Dexamethasone—hematologic cancer	2.7e-05	0.000132	CcSEcCtD
Methadone—Dizziness—Betamethasone—hematologic cancer	2.7e-05	0.000132	CcSEcCtD
Methadone—Hyperhidrosis—Epirubicin—hematologic cancer	2.69e-05	0.000131	CcSEcCtD
Methadone—Insomnia—Methotrexate—hematologic cancer	2.69e-05	0.000131	CcSEcCtD
Methadone—Anxiety—Doxorubicin—hematologic cancer	2.68e-05	0.00013	CcSEcCtD
Methadone—Nausea—Triamcinolone—hematologic cancer	2.68e-05	0.00013	CcSEcCtD
Methadone—Anorexia—Epirubicin—hematologic cancer	2.65e-05	0.000129	CcSEcCtD
Methadone—Somnolence—Methotrexate—hematologic cancer	2.64e-05	0.000129	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—hematologic cancer	2.63e-05	0.000128	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—hematologic cancer	2.62e-05	0.000128	CcSEcCtD
Methadone—Hypotension—Epirubicin—hematologic cancer	2.6e-05	0.000127	CcSEcCtD
Methadone—Vomiting—Betamethasone—hematologic cancer	2.6e-05	0.000126	CcSEcCtD
Methadone—Vomiting—Dexamethasone—hematologic cancer	2.6e-05	0.000126	CcSEcCtD
Methadone—Confusional state—Doxorubicin—hematologic cancer	2.6e-05	0.000126	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—hematologic cancer	2.59e-05	0.000126	CcSEcCtD
Methadone—Rash—Betamethasone—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Methadone—Rash—Dexamethasone—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Methadone—Oedema—Doxorubicin—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Methadone—Dermatitis—Dexamethasone—hematologic cancer	2.57e-05	0.000125	CcSEcCtD
Methadone—Dermatitis—Betamethasone—hematologic cancer	2.57e-05	0.000125	CcSEcCtD
Methadone—Headache—Betamethasone—hematologic cancer	2.56e-05	0.000125	CcSEcCtD
Methadone—Headache—Dexamethasone—hematologic cancer	2.56e-05	0.000125	CcSEcCtD
Methadone—Asthenia—Prednisone—hematologic cancer	2.55e-05	0.000124	CcSEcCtD
Methadone—Pain—Methotrexate—hematologic cancer	2.54e-05	0.000124	CcSEcCtD
Methadone—Shock—Doxorubicin—hematologic cancer	2.53e-05	0.000123	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.52e-05	0.000123	CcSEcCtD
Methadone—Pruritus—Prednisone—hematologic cancer	2.52e-05	0.000123	CcSEcCtD
Methadone—Insomnia—Epirubicin—hematologic cancer	2.52e-05	0.000123	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—hematologic cancer	2.51e-05	0.000122	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.49e-05	0.000121	CcSEcCtD
Methadone—Somnolence—Epirubicin—hematologic cancer	2.47e-05	0.00012	CcSEcCtD
Methadone—Anorexia—Doxorubicin—hematologic cancer	2.46e-05	0.000119	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—hematologic cancer	2.45e-05	0.000119	CcSEcCtD
Methadone—Diarrhoea—Prednisone—hematologic cancer	2.44e-05	0.000119	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.43e-05	0.000118	CcSEcCtD
Methadone—Nausea—Betamethasone—hematologic cancer	2.43e-05	0.000118	CcSEcCtD
Methadone—Nausea—Dexamethasone—hematologic cancer	2.43e-05	0.000118	CcSEcCtD
Methadone—Decreased appetite—Epirubicin—hematologic cancer	2.42e-05	0.000118	CcSEcCtD
Methadone—Hypotension—Doxorubicin—hematologic cancer	2.41e-05	0.000117	CcSEcCtD
Methadone—Pain—Epirubicin—hematologic cancer	2.38e-05	0.000116	CcSEcCtD
Methadone—Constipation—Epirubicin—hematologic cancer	2.38e-05	0.000116	CcSEcCtD
Methadone—Urticaria—Methotrexate—hematologic cancer	2.36e-05	0.000115	CcSEcCtD
Methadone—Dizziness—Prednisone—hematologic cancer	2.35e-05	0.000115	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Methadone—Insomnia—Doxorubicin—hematologic cancer	2.33e-05	0.000113	CcSEcCtD
Methadone—Feeling abnormal—Epirubicin—hematologic cancer	2.29e-05	0.000112	CcSEcCtD
Methadone—Somnolence—Doxorubicin—hematologic cancer	2.29e-05	0.000111	CcSEcCtD
Methadone—Gastrointestinal pain—Epirubicin—hematologic cancer	2.28e-05	0.000111	CcSEcCtD
Methadone—Vomiting—Prednisone—hematologic cancer	2.26e-05	0.00011	CcSEcCtD
Methadone—Rash—Prednisone—hematologic cancer	2.24e-05	0.000109	CcSEcCtD
Methadone—Dermatitis—Prednisone—hematologic cancer	2.24e-05	0.000109	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—hematologic cancer	2.24e-05	0.000109	CcSEcCtD
Methadone—Headache—Prednisone—hematologic cancer	2.23e-05	0.000109	CcSEcCtD
Methadone—Urticaria—Epirubicin—hematologic cancer	2.21e-05	0.000108	CcSEcCtD
Methadone—Pain—Doxorubicin—hematologic cancer	2.2e-05	0.000107	CcSEcCtD
Methadone—Constipation—Doxorubicin—hematologic cancer	2.2e-05	0.000107	CcSEcCtD
Methadone—Abdominal pain—Epirubicin—hematologic cancer	2.2e-05	0.000107	CcSEcCtD
Methadone—Body temperature increased—Epirubicin—hematologic cancer	2.2e-05	0.000107	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—hematologic cancer	2.19e-05	0.000107	CcSEcCtD
Methadone—Asthenia—Methotrexate—hematologic cancer	2.13e-05	0.000104	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—hematologic cancer	2.12e-05	0.000103	CcSEcCtD
Methadone—Nausea—Prednisone—hematologic cancer	2.11e-05	0.000103	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.11e-05	0.000102	CcSEcCtD
Methadone—Pruritus—Methotrexate—hematologic cancer	2.1e-05	0.000102	CcSEcCtD
Methadone—Hypersensitivity—Epirubicin—hematologic cancer	2.05e-05	9.98e-05	CcSEcCtD
Methadone—Urticaria—Doxorubicin—hematologic cancer	2.05e-05	9.96e-05	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—hematologic cancer	2.04e-05	9.91e-05	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—hematologic cancer	2.04e-05	9.91e-05	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—hematologic cancer	2.04e-05	9.9e-05	CcSEcCtD
Methadone—Asthenia—Epirubicin—hematologic cancer	2e-05	9.72e-05	CcSEcCtD
Methadone—Pruritus—Epirubicin—hematologic cancer	1.97e-05	9.58e-05	CcSEcCtD
Methadone—Dizziness—Methotrexate—hematologic cancer	1.97e-05	9.57e-05	CcSEcCtD
Methadone—Diarrhoea—Epirubicin—hematologic cancer	1.9e-05	9.27e-05	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—hematologic cancer	1.9e-05	9.23e-05	CcSEcCtD
Methadone—Vomiting—Methotrexate—hematologic cancer	1.89e-05	9.2e-05	CcSEcCtD
Methadone—Rash—Methotrexate—hematologic cancer	1.88e-05	9.13e-05	CcSEcCtD
Methadone—Dermatitis—Methotrexate—hematologic cancer	1.87e-05	9.12e-05	CcSEcCtD
Methadone—Headache—Methotrexate—hematologic cancer	1.86e-05	9.07e-05	CcSEcCtD
Methadone—Asthenia—Doxorubicin—hematologic cancer	1.85e-05	8.99e-05	CcSEcCtD
Methadone—Dizziness—Epirubicin—hematologic cancer	1.84e-05	8.96e-05	CcSEcCtD
Methadone—Pruritus—Doxorubicin—hematologic cancer	1.82e-05	8.87e-05	CcSEcCtD
Methadone—Vomiting—Epirubicin—hematologic cancer	1.77e-05	8.61e-05	CcSEcCtD
Methadone—Nausea—Methotrexate—hematologic cancer	1.77e-05	8.6e-05	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—hematologic cancer	1.76e-05	8.58e-05	CcSEcCtD
Methadone—Rash—Epirubicin—hematologic cancer	1.76e-05	8.54e-05	CcSEcCtD
Methadone—Dermatitis—Epirubicin—hematologic cancer	1.75e-05	8.53e-05	CcSEcCtD
Methadone—Headache—Epirubicin—hematologic cancer	1.74e-05	8.49e-05	CcSEcCtD
Methadone—Dizziness—Doxorubicin—hematologic cancer	1.7e-05	8.29e-05	CcSEcCtD
Methadone—Nausea—Epirubicin—hematologic cancer	1.65e-05	8.05e-05	CcSEcCtD
Methadone—Vomiting—Doxorubicin—hematologic cancer	1.64e-05	7.97e-05	CcSEcCtD
Methadone—Rash—Doxorubicin—hematologic cancer	1.62e-05	7.9e-05	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—hematologic cancer	1.62e-05	7.9e-05	CcSEcCtD
Methadone—Headache—Doxorubicin—hematologic cancer	1.61e-05	7.85e-05	CcSEcCtD
Methadone—Nausea—Doxorubicin—hematologic cancer	1.53e-05	7.45e-05	CcSEcCtD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.1e-06	4.78e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	3.09e-06	4.75e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYCS—hematologic cancer	3.09e-06	4.75e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	3.07e-06	4.72e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.07e-06	4.72e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.07e-06	4.72e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	3.06e-06	4.71e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYCS—hematologic cancer	3.06e-06	4.71e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.06e-06	4.71e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.05e-06	4.69e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.05e-06	4.69e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.04e-06	4.68e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	3.04e-06	4.68e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.03e-06	4.66e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.03e-06	4.66e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	3.02e-06	4.65e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3e-06	4.62e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3e-06	4.61e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.99e-06	4.6e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.99e-06	4.6e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.96e-06	4.55e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.96e-06	4.55e-05	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.96e-06	4.55e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.95e-06	4.54e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.93e-06	4.51e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.93e-06	4.51e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.92e-06	4.5e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.92e-06	4.49e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.91e-06	4.48e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.91e-06	4.48e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—hematologic cancer	2.89e-06	4.44e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.86e-06	4.4e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.86e-06	4.4e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.85e-06	4.39e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.84e-06	4.38e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.83e-06	4.36e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.83e-06	4.36e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.81e-06	4.32e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.8e-06	4.31e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2.8e-06	4.31e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.78e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.77e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.77e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.77e-06	4.26e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.77e-06	4.26e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NQO1—hematologic cancer	2.76e-06	4.25e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CD44—hematologic cancer	2.76e-06	4.25e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.76e-06	4.24e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.75e-06	4.24e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—hematologic cancer	2.75e-06	4.24e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2.75e-06	4.23e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.74e-06	4.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.72e-06	4.19e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.72e-06	4.18e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.72e-06	4.18e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.71e-06	4.16e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTR—hematologic cancer	2.7e-06	4.15e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.7e-06	4.15e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.7e-06	4.15e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.69e-06	4.14e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	2.69e-06	4.14e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	2.69e-06	4.14e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.69e-06	4.14e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	2.68e-06	4.13e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	2.68e-06	4.13e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.67e-06	4.11e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.65e-06	4.08e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.65e-06	4.08e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.65e-06	4.07e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—EP300—hematologic cancer	2.63e-06	4.04e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EP300—hematologic cancer	2.62e-06	4.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYCS—hematologic cancer	2.62e-06	4.02e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.61e-06	4.02e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.61e-06	4.02e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—hematologic cancer	2.61e-06	4.01e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	2.6e-06	4e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.6e-06	4e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.58e-06	3.96e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	2.57e-06	3.95e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.57e-06	3.95e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.55e-06	3.93e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SRC—hematologic cancer	2.55e-06	3.93e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—hematologic cancer	2.54e-06	3.91e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.53e-06	3.89e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.51e-06	3.86e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.5e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.5e-06	3.85e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.5e-06	3.84e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.49e-06	3.82e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.48e-06	3.81e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.48e-06	3.81e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.48e-06	3.81e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.48e-06	3.81e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.47e-06	3.8e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.46e-06	3.79e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.46e-06	3.78e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.45e-06	3.78e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.42e-06	3.73e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	2.41e-06	3.71e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.41e-06	3.71e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.4e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.4e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.39e-06	3.68e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.37e-06	3.65e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	2.35e-06	3.62e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.35e-06	3.61e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—hematologic cancer	2.35e-06	3.61e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.34e-06	3.6e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.33e-06	3.59e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.33e-06	3.58e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—hematologic cancer	2.32e-06	3.57e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.31e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.3e-06	3.53e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—hematologic cancer	2.29e-06	3.52e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—EP300—hematologic cancer	2.28e-06	3.51e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	2.28e-06	3.51e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.27e-06	3.5e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.27e-06	3.49e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—hematologic cancer	2.27e-06	3.49e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.26e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.23e-06	3.43e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.22e-06	3.41e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.22e-06	3.41e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.21e-06	3.41e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.21e-06	3.4e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.19e-06	3.37e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.18e-06	3.36e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.17e-06	3.34e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.16e-06	3.32e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—hematologic cancer	2.14e-06	3.3e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CD44—hematologic cancer	2.13e-06	3.28e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.13e-06	3.28e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.12e-06	3.26e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.12e-06	3.26e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.12e-06	3.26e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	2.11e-06	3.25e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	2.1e-06	3.23e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.1e-06	3.23e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	2.08e-06	3.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	2.07e-06	3.19e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—hematologic cancer	2.07e-06	3.19e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	2.05e-06	3.15e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.05e-06	3.15e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.02e-06	3.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.02e-06	3.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.01e-06	3.09e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2e-06	3.08e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.99e-06	3.06e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.99e-06	3.06e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.97e-06	3.03e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—hematologic cancer	1.96e-06	3.02e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.96e-06	3.02e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—hematologic cancer	1.94e-06	2.99e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.94e-06	2.99e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.93e-06	2.97e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.93e-06	2.97e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.93e-06	2.97e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.88e-06	2.89e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.88e-06	2.89e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.87e-06	2.88e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.87e-06	2.88e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.86e-06	2.86e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.84e-06	2.83e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.83e-06	2.81e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.81e-06	2.78e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.8e-06	2.76e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.79e-06	2.75e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.78e-06	2.74e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.77e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—hematologic cancer	1.77e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—hematologic cancer	1.75e-06	2.7e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.73e-06	2.67e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.73e-06	2.67e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.73e-06	2.66e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.72e-06	2.65e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.72e-06	2.64e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—hematologic cancer	1.71e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.71e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.69e-06	2.6e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—EP300—hematologic cancer	1.69e-06	2.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.68e-06	2.59e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.68e-06	2.58e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.65e-06	2.54e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—EP300—hematologic cancer	1.65e-06	2.54e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.64e-06	2.52e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.64e-06	2.52e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.63e-06	2.52e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.63e-06	2.52e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.63e-06	2.51e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.62e-06	2.49e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—hematologic cancer	1.61e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—hematologic cancer	1.6e-06	2.46e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—hematologic cancer	1.59e-06	2.44e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.59e-06	2.44e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.59e-06	2.44e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.57e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.55e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.54e-06	2.37e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.53e-06	2.35e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.52e-06	2.34e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.51e-06	2.32e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.5e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.46e-06	2.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.45e-06	2.24e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.44e-06	2.22e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—EP300—hematologic cancer	1.43e-06	2.2e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.42e-06	2.19e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.17e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.38e-06	2.13e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.38e-06	2.12e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—hematologic cancer	1.37e-06	2.1e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.34e-06	2.06e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—hematologic cancer	1.34e-06	2.06e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.31e-06	2.01e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—hematologic cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—EP300—hematologic cancer	1.27e-06	1.96e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.92e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—EP300—hematologic cancer	1.24e-06	1.91e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.23e-06	1.89e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.22e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.22e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.21e-06	1.87e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—EP300—hematologic cancer	1.17e-06	1.8e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—EP300—hematologic cancer	1.16e-06	1.79e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.13e-06	1.73e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.07e-06	1.64e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—hematologic cancer	1.05e-06	1.62e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—hematologic cancer	1.04e-06	1.6e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—hematologic cancer	1.02e-06	1.57e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.01e-06	1.55e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—hematologic cancer	9.96e-07	1.53e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—EP300—hematologic cancer	9.93e-07	1.53e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.43e-07	1.45e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.3e-07	1.43e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.2e-07	1.42e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.67e-07	1.33e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—hematologic cancer	8.63e-07	1.33e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.6e-07	1.32e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—hematologic cancer	8.04e-07	1.24e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—hematologic cancer	7.7e-07	1.19e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—EP300—hematologic cancer	7.67e-07	1.18e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—hematologic cancer	7.52e-07	1.16e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.35e-07	1.13e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—hematologic cancer	7.09e-07	1.09e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—hematologic cancer	7.02e-07	1.08e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—hematologic cancer	6e-07	9.24e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.67e-07	8.73e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—hematologic cancer	4.63e-07	7.13e-06	CbGpPWpGaD
